BACKGROUND: The German Dementia Competence Network (DCN) has established procedures for standardized multicenter acquisition of clinical, biological and imaging data, for centralized data management, and for the evaluation of new treatments. METHODS: A longitudinal cohort study was set up for patients with mild cognitive impairment (MCI), patients with mild dementia and control subjects. The aims were to establish the diagnostic, differential diagnostic and prognostic power of a range of clinical, laboratory and imaging methods. Furthermore, 2 clinical trials were conducted with patients suffering from MCI and mild to moderate Alzheimer's Disease (AD). These trials aimed at evaluating the efficacy and safety of the combination of galantamine and memantine versus galantamine alone. RESULTS: Here, we report on the scope and projects of the DCN, the methods that were employed, the composition and flow within the diverse groups of patients and control persons and on the clinical and neuropsychological baseline characteristics of the group of 2,113 subjects who participated in the observational and clinical trials. CONCLUSION: These data have an impact on the procedures for the early and differential clinical diagnosis of dementias, the current standard treatment of AD as well as on future clinical trials in AD.
BACKGROUND: The German Dementia Competence Network (DCN) has established procedures for standardized multicenter acquisition of clinical, biological and imaging data, for centralized data management, and for the evaluation of new treatments. METHODS: A longitudinal cohort study was set up for patients with mild cognitive impairment (MCI), patients with mild dementia and control subjects. The aims were to establish the diagnostic, differential diagnostic and prognostic power of a range of clinical, laboratory and imaging methods. Furthermore, 2 clinical trials were conducted with patients suffering from MCI and mild to moderate Alzheimer's Disease (AD). These trials aimed at evaluating the efficacy and safety of the combination of galantamine and memantine versus galantamine alone. RESULTS: Here, we report on the scope and projects of the DCN, the methods that were employed, the composition and flow within the diverse groups of patients and control persons and on the clinical and neuropsychological baseline characteristics of the group of 2,113 subjects who participated in the observational and clinical trials. CONCLUSION: These data have an impact on the procedures for the early and differential clinical diagnosis of dementias, the current standard treatment of AD as well as on future clinical trials in AD.
Authors: K Blennow; G De Meyer; O Hansson; L Minthon; A Wallin; H Zetterberg; P Lewczuk; H Vanderstichele; E Vanmechelen; J Kornhuber; J Wiltfang; I Heuser; W Maier; C Luckhaus; E Rüther; M Hüll; H Jahn; H J Gertz; L Frölich; H Hampel; R Pernetzki Journal: J Nutr Health Aging Date: 2009-03 Impact factor: 4.075
Authors: Stefanie Heilmann; Dmitriy Drichel; Jordi Clarimon; Victoria Fernández; André Lacour; Holger Wagner; Mathias Thelen; Isabel Hernández; Juan Fortea; Montserrat Alegret; Rafael Blesa; Ana Mauleón; Maitée Rosende Roca; Johannes Kornhuber; Oliver Peters; Reinhard Heun; Lutz Frölich; Michael Hüll; Michael T Heneka; Eckart Rüther; Steffi Riedel-Heller; Martin Scherer; Jens Wiltfang; Frank Jessen; Tim Becker; Lluís Tárraga; Mercè Boada; Wolfgang Maier; Alberto Lleó; Agustin Ruiz; Markus M Nöthen; Alfredo Ramirez Journal: Nature Date: 2015-04-02 Impact factor: 49.962
Authors: Nienke M E Scheltens; Betty M Tijms; Teddy Koene; Frederik Barkhof; Charlotte E Teunissen; Steffen Wolfsgruber; Michael Wagner; Johannes Kornhuber; Oliver Peters; Brendan I Cohn-Sheehy; Gil D Rabinovici; Bruce L Miller; Joel H Kramer; Philip Scheltens; Wiesje M van der Flier Journal: Alzheimers Dement Date: 2017-04-17 Impact factor: 21.566
Authors: Alfredo Ramirez; Wiesje M van der Flier; Christine Herold; David Ramonet; Stefanie Heilmann; Piotr Lewczuk; Julius Popp; André Lacour; Dmitriy Drichel; Eva Louwersheimer; Markus P Kummer; Carlos Cruchaga; Per Hoffmann; Charlotte Teunissen; Henne Holstege; Johannes Kornhuber; Oliver Peters; Adam C Naj; Vincent Chouraki; Céline Bellenguez; Amy Gerrish; Reiner Heun; Lutz Frölich; Michael Hüll; Lara Buscemi; Stefan Herms; Heike Kölsch; Philip Scheltens; Monique M Breteler; Eckart Rüther; Jens Wiltfang; Alison Goate; Frank Jessen; Wolfgang Maier; Michael T Heneka; Tim Becker; Markus M Nöthen Journal: Hum Mol Genet Date: 2014-07-15 Impact factor: 6.150
Authors: Rosalinde E R Slot; Sietske A M Sikkes; Johannes Berkhof; Henry Brodaty; Rachel Buckley; Enrica Cavedo; Efthimios Dardiotis; Francoise Guillo-Benarous; Harald Hampel; Nicole A Kochan; Simone Lista; Tobias Luck; Paul Maruff; José Luis Molinuevo; Johannes Kornhuber; Barry Reisberg; Steffi G Riedel-Heller; Shannon L Risacher; Susanne Roehr; Perminder S Sachdev; Nikolaos Scarmeas; Philip Scheltens; Melanie B Shulman; Andrew J Saykin; Sander C J Verfaillie; Pieter Jelle Visser; Stephanie J B Vos; Michael Wagner; Steffen Wolfsgruber; Frank Jessen; Wiesje M van der Flier Journal: Alzheimers Dement Date: 2018-12-13 Impact factor: 21.566
Authors: Basavaraj V Hooli; Antonio R Parrado; Kristina Mullin; Wai-Ki Yip; Tian Liu; Johannes T Roehr; Dandi Qiao; Frank Jessen; Oliver Peters; Tim Becker; Alfredo Ramirez; Christoph Lange; Lars Bertram; Rudolph E Tanzi Journal: Neurology Date: 2014-09-03 Impact factor: 9.910
Authors: Piotr Lewczuk; Johannes Kornhuber; Jon B Toledo; John Q Trojanowski; Malgorzata Knapik-Czajka; Oliver Peters; Jens Wiltfang; Leslie M Shaw Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Maria A de Souza Silva; Bernd Lenz; Andrea Rotter; Teresa Biermann; Oliver Peters; Alfredo Ramirez; Frank Jessen; Wolfgang Maier; Michael Hüll; Johannes Schröder; Lutz Frölich; Stefan Teipel; Oliver Gruber; Johannes Kornhuber; Joseph P Huston; Christian P Müller; Sandra Schäble Journal: Proc Natl Acad Sci U S A Date: 2013-08-27 Impact factor: 11.205